Oxford Nanopore Technologies (ONT) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Aug 2023 05:30 PM
RNS
Issue of Equity and Total Voting Rights
17 Jul 2023 07:00 AM
RNS
Half Year Trading Update
13 Jul 2023 03:30 PM
RNS
Kate Priestman appointed as Non-Executive Director
11 Jul 2023 05:30 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
03 Jul 2023 03:30 PM
RNS
Issue of Equity and Total Voting Rights
13 Jun 2023 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
12 Jun 2023 03:30 PM
RNS
Result of AGM
12 Jun 2023 07:00 AM
RNS
National German rare disease study
09 Jun 2023 07:00 AM
RNS
Change of Broker
01 Jun 2023 03:00 PM
RNS
Issue of Equity and Total Voting Rights
19 May 2023 07:00 AM
RNS
London Calling Technology Update
12 May 2023 01:30 PM
RNS
Holding(s) in Company
12 May 2023 08:35 AM
RNS
Next step of PathoQuest strategic collaboration
11 May 2023 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
04 May 2023 04:30 PM
RNS
Director/PDMR Notification
02 May 2023 03:00 PM
RNS
Issue of Equity and Total Voting Rights
26 Apr 2023 07:00 AM
RNS
Publication of Annual Report and Notice of AGM
17 Apr 2023 07:00 AM
RNS
New infectious disease partnership with bioMerieux
13 Apr 2023 06:00 PM
RNS
Director/PDMR Shareholding
12 Apr 2023 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
12 Apr 2023 04:00 PM
RNS
LTIP and DBP; Director/PDMR Notification
11 Apr 2023 07:00 AM
RNS
NIH Alzheimers study shows scaled, accurate data
06 Apr 2023 04:00 PM
RNS
Block listing Interim Review
03 Apr 2023 03:30 PM
RNS
Issue of Equity and Total Voting Rights
31 Mar 2023 07:00 AM
RNS
NIHR, Oxford Nanopore announce new health study
21 Mar 2023 07:00 AM
RNS
Final results for the year ended 31 December 2022
13 Mar 2023 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
09 Mar 2023 07:00 AM
RNS
Notice of Results
01 Mar 2023 03:30 PM
RNS
Issue of Equity and Total Voting Rights
27 Feb 2023 06:00 PM
RNS
Changes to Director Roles and Responsibilities
13 Feb 2023 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Feb 2023 04:30 PM
RNS
Total Voting Rights and Issue of Equity
17 Jan 2023 07:00 AM
RNS
Trading update
13 Jan 2023 03:30 PM
RNS
Director/PDMR Shareholding (ESPP)
11 Jan 2023 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
04 Jan 2023 05:30 PM
RNS
Director/PDMR Shareholding (ESPP)
03 Jan 2023 05:00 PM
RNS
Issue of equity and Total Voting Rights
28 Dec 2022 03:00 PM
RNS
Holding(s) in Company
23 Dec 2022 12:00 PM
RNS
Holding(s) in Company
13 Dec 2022 04:50 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Dec 2022 03:00 PM
RNS
Issue of Equity and Total Voting Rights
11 Nov 2022 04:30 PM
RNS
Director/PDMR Shareholding
11 Nov 2022 04:30 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Nov 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
11 Oct 2022 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
10 Oct 2022 12:00 PM
RNS
Director/PDMR Shareholding
06 Oct 2022 05:30 PM
RNS
Block listing Interim Review
03 Oct 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
29 Sep 2022 09:00 AM
RNS
Director/PDMR Shareholding
14 Sep 2022 11:00 AM
RNS
Director/PDMR Shareholding

Oxford Nanopore Technologies develops electronic sensing systems for analyzing DNA, RNA, proteins, and other molecules including DNA sequencing, diagnostics and drug development using uses nanopore science to develop single-molecule sensing systems. Their products are used in research areas such as microbiology, human genetics, cancer research, and plant research.

Founded in 2005 as a spin-out from the University of Oxford, Oxford Nanopore is listed in London under the ticker ONT.

Oxford Nanopore share price listed at 615p in 2021.

UK 100

Latest directors dealings